Get the full picture
Sign in to uncover key details.
Cytonics
Blood & Organ Banks · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
658 W Indiantown Rd Ste 214, Jupiter, Fl...Phone Number
(561) 406-2864Website
www.cytonics.comRevenue
<$5 MillionIndustry
About Cytonics
Cytonics Corporation is a clinical-stage biotechnology company focused on developing innovative treatments for osteoarthritis, the most common joint disease. Utilizing Alpha-2-Macroglobulin (A2M), Cytonics has created a novel biologic, CYT-108, which aims to target the molecular causes of cartilage degradation and potentially reverse osteoarthritis progression. The company seeks to provide effective therapies where traditional medications have failed, emphasizing a patient-centered approach. Cytonics is committed to pioneering drug discovery and addressing the shortcomings of existing pharmaceutical solutions.Explore more
Cytonics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Cytonics Tech Stack
A closer look at the technologies used by Cytonics
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cytonics
Sign Up For FreeTo access detailed company insights
Cytonics Corporation is a clinical-stage biotechnology company focused on developing innovative treatments for osteoarthritis, the most common joint disease. Utilizing Alpha-2-Macroglobulin (A2M), Cytonics has created a novel biologic, CYT-108, which aims to target the molecular causes of cartilage degradation and potentially reverse osteoarthritis... Read More
